primary antibody ve cadherin Search Results


96
R&D Systems anti ve cadherin
Anti Ve Cadherin, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibody+ve+cadherin/bio_rxiv__2020__02__11__943183-258-25-27?v=R%26D+Systems
Average 96 stars, based on 1 article reviews
anti ve cadherin - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

96
R&D Systems ve cadherin
Ve Cadherin, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibody+ve+cadherin/10__1096_slash_fj__202001634r-118-22-25?v=R%26D+Systems
Average 96 stars, based on 1 article reviews
ve cadherin - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

91
Novus Biologicals ve cadherin nbp1 43347 antibodies
Ve Cadherin Nbp1 43347 Antibodies, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibody+ve+cadherin/pmc06487725-16-8-14?v=Novus+Biologicals
Average 91 stars, based on 1 article reviews
ve cadherin nbp1 43347 antibodies - by Bioz Stars, 2026-08
91/100 stars
  Buy from Supplier

93
R&D Systems human ve cadherin alexa fluor 488 conjugated antibody
Human Ve Cadherin Alexa Fluor 488 Conjugated Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibody+ve+cadherin/pmc12910434-215-4-10?v=R%26D+Systems
Average 93 stars, based on 1 article reviews
human ve cadherin alexa fluor 488 conjugated antibody - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology mouse igg1 anti human cdh5 ve cadherin
Mouse Igg1 Anti Human Cdh5 Ve Cadherin, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibody+ve+cadherin/pm41566484-128-142-148?v=Santa+Cruz+Biotechnology
Average 96 stars, based on 1 article reviews
mouse igg1 anti human cdh5 ve cadherin - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

95
R&D Systems goat anti ve cadherin
Goat Anti Ve Cadherin, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibody+ve+cadherin/pm41951642-254-77-79?v=R%26D+Systems
Average 95 stars, based on 1 article reviews
goat anti ve cadherin - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology sc 722 rrid ab 2108502 antibody ve cadherin
Sc 722 Rrid Ab 2108502 Antibody Ve Cadherin, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibody+ve+cadherin/10__7554_slash_elife__41044-156-68-75?v=Santa+Cruz+Biotechnology
Average 93 stars, based on 1 article reviews
sc 722 rrid ab 2108502 antibody ve cadherin - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

93
R&D Systems cd144
Fig. 1. EPC morphology and gene expression. (A) Appearance of a freshly isolated EPC colony at passage 0 on day 9 of culture. (B) Appearance of EPCs in culture at passage 2, (C–F) EPCs express the endothelial cell specific markers CD31 (C, red, DAPI blue) and <t>CD144</t> (D, green, DAPI blue) and pluripotency associated markers NANOG (E, red) and REX-1 (F, red, DAPI blue). Images A-B at 50X magnification, images C, D, E, F at 100X magnification.
Cd144, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibody+ve+cadherin/pm33588094-64-16-20?v=R%26D+Systems
Average 93 stars, based on 1 article reviews
cd144 - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc ve cadherin
Figure <t>7</t> <t>VEGFR-2</t> and <t>VE-cadherin</t> staining (A, B) Representative immunohistochemical VEGFR-2 staining of skin wounds samples from diabetic (db + /db + ) mice treated with vehicle (6 μl of 0.9 % NaCl/mouse per day) or RLX (25 μg/mouse per day, subcutaneously) at day 12. Arrows indicate staining positivity. (C, D) Representative immunohistochemical VE-cadherin staining of skin wounds samples from diabetic (db + /db + ) mice treated with vehicle (6 μl of 0.9 % NaCl/mouse per day) or RLX (25 μg/mouse per day, subcutaneously) at day 12. Arrows indicate staining positivity. (C, F) Quantification of VEGFR-2- and VE-Cadherin-positive cells per field in normoglycaemic (db + / + m) and diabetic (db + /db + ) mice treated with vehicle (6 μl of 0.9 % NaCl/mouse per day) or with RLX (25 μg/mouse per day, subcutaneously) at day 12. Each bar represents the mean +−S.D. of six animals. *P < 0.05 compared with db + / + m + vehicle; §P < 0.01 compared with db + / + m + vehicle; #P < 0.01 compared with db + /db + + vehicle.
Ve Cadherin, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibody+ve+cadherin/10__1042_slash_cs20130105-76-12-19?v=Cell+Signaling+Technology+Inc
Average 96 stars, based on 1 article reviews
ve cadherin - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

96
Proteintech ve cadherin
Figure <t>7</t> <t>VEGFR-2</t> and <t>VE-cadherin</t> staining (A, B) Representative immunohistochemical VEGFR-2 staining of skin wounds samples from diabetic (db + /db + ) mice treated with vehicle (6 μl of 0.9 % NaCl/mouse per day) or RLX (25 μg/mouse per day, subcutaneously) at day 12. Arrows indicate staining positivity. (C, D) Representative immunohistochemical VE-cadherin staining of skin wounds samples from diabetic (db + /db + ) mice treated with vehicle (6 μl of 0.9 % NaCl/mouse per day) or RLX (25 μg/mouse per day, subcutaneously) at day 12. Arrows indicate staining positivity. (C, F) Quantification of VEGFR-2- and VE-Cadherin-positive cells per field in normoglycaemic (db + / + m) and diabetic (db + /db + ) mice treated with vehicle (6 μl of 0.9 % NaCl/mouse per day) or with RLX (25 μg/mouse per day, subcutaneously) at day 12. Each bar represents the mean +−S.D. of six animals. *P < 0.05 compared with db + / + m + vehicle; §P < 0.01 compared with db + / + m + vehicle; #P < 0.01 compared with db + /db + + vehicle.
Ve Cadherin, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibody+ve+cadherin/pmc12809916-100-52-55?v=Proteintech
Average 96 stars, based on 1 article reviews
ve cadherin - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

91
R&D Systems rat ve cadherin mab
Figure <t>7</t> <t>VEGFR-2</t> and <t>VE-cadherin</t> staining (A, B) Representative immunohistochemical VEGFR-2 staining of skin wounds samples from diabetic (db + /db + ) mice treated with vehicle (6 μl of 0.9 % NaCl/mouse per day) or RLX (25 μg/mouse per day, subcutaneously) at day 12. Arrows indicate staining positivity. (C, D) Representative immunohistochemical VE-cadherin staining of skin wounds samples from diabetic (db + /db + ) mice treated with vehicle (6 μl of 0.9 % NaCl/mouse per day) or RLX (25 μg/mouse per day, subcutaneously) at day 12. Arrows indicate staining positivity. (C, F) Quantification of VEGFR-2- and VE-Cadherin-positive cells per field in normoglycaemic (db + / + m) and diabetic (db + /db + ) mice treated with vehicle (6 μl of 0.9 % NaCl/mouse per day) or with RLX (25 μg/mouse per day, subcutaneously) at day 12. Each bar represents the mean +−S.D. of six animals. *P < 0.05 compared with db + / + m + vehicle; §P < 0.01 compared with db + / + m + vehicle; #P < 0.01 compared with db + /db + + vehicle.
Rat Ve Cadherin Mab, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibody+ve+cadherin/10__1158_slash_0008___5472__can___10___1138-62-10-14?v=R%26D+Systems
Average 91 stars, based on 1 article reviews
rat ve cadherin mab - by Bioz Stars, 2026-08
91/100 stars
  Buy from Supplier

96
R&D Systems pab af938 if
Figure <t>7</t> <t>VEGFR-2</t> and <t>VE-cadherin</t> staining (A, B) Representative immunohistochemical VEGFR-2 staining of skin wounds samples from diabetic (db + /db + ) mice treated with vehicle (6 μl of 0.9 % NaCl/mouse per day) or RLX (25 μg/mouse per day, subcutaneously) at day 12. Arrows indicate staining positivity. (C, D) Representative immunohistochemical VE-cadherin staining of skin wounds samples from diabetic (db + /db + ) mice treated with vehicle (6 μl of 0.9 % NaCl/mouse per day) or RLX (25 μg/mouse per day, subcutaneously) at day 12. Arrows indicate staining positivity. (C, F) Quantification of VEGFR-2- and VE-Cadherin-positive cells per field in normoglycaemic (db + / + m) and diabetic (db + /db + ) mice treated with vehicle (6 μl of 0.9 % NaCl/mouse per day) or with RLX (25 μg/mouse per day, subcutaneously) at day 12. Each bar represents the mean +−S.D. of six animals. *P < 0.05 compared with db + / + m + vehicle; §P < 0.01 compared with db + / + m + vehicle; #P < 0.01 compared with db + /db + + vehicle.
Pab Af938 If, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibody+ve+cadherin/pmc13043941-410-28-31?v=R%26D+Systems
Average 96 stars, based on 1 article reviews
pab af938 if - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

Image Search Results


Fig. 1. EPC morphology and gene expression. (A) Appearance of a freshly isolated EPC colony at passage 0 on day 9 of culture. (B) Appearance of EPCs in culture at passage 2, (C–F) EPCs express the endothelial cell specific markers CD31 (C, red, DAPI blue) and CD144 (D, green, DAPI blue) and pluripotency associated markers NANOG (E, red) and REX-1 (F, red, DAPI blue). Images A-B at 50X magnification, images C, D, E, F at 100X magnification.

Journal: New biotechnology

Article Title: Clinically compatible advances in blood-derived endothelial progenitor cell isolation and reprogramming for translational applications.

doi: 10.1016/j.nbt.2021.02.001

Figure Lengend Snippet: Fig. 1. EPC morphology and gene expression. (A) Appearance of a freshly isolated EPC colony at passage 0 on day 9 of culture. (B) Appearance of EPCs in culture at passage 2, (C–F) EPCs express the endothelial cell specific markers CD31 (C, red, DAPI blue) and CD144 (D, green, DAPI blue) and pluripotency associated markers NANOG (E, red) and REX-1 (F, red, DAPI blue). Images A-B at 50X magnification, images C, D, E, F at 100X magnification.

Article Snippet: Primary EPCs were stained using specific antibodies against CD31 (Cat. no. BBA7, R&D Systems, Abingdon, UK), CD144 (Cat. no. MAB9381, R&D Systems) and REX1 (Cat. no. AF3598, R&D Systems), or by using ULEX (Cat. no. RL-1062-2, Vector Laboratories) or DAPI (Cat. no. H-1200-10, Vector Laboratories) at the dilution recommended by the manufacturer.

Techniques: Gene Expression, Isolation

Figure 7 VEGFR-2 and VE-cadherin staining (A, B) Representative immunohistochemical VEGFR-2 staining of skin wounds samples from diabetic (db + /db + ) mice treated with vehicle (6 μl of 0.9 % NaCl/mouse per day) or RLX (25 μg/mouse per day, subcutaneously) at day 12. Arrows indicate staining positivity. (C, D) Representative immunohistochemical VE-cadherin staining of skin wounds samples from diabetic (db + /db + ) mice treated with vehicle (6 μl of 0.9 % NaCl/mouse per day) or RLX (25 μg/mouse per day, subcutaneously) at day 12. Arrows indicate staining positivity. (C, F) Quantification of VEGFR-2- and VE-Cadherin-positive cells per field in normoglycaemic (db + / + m) and diabetic (db + /db + ) mice treated with vehicle (6 μl of 0.9 % NaCl/mouse per day) or with RLX (25 μg/mouse per day, subcutaneously) at day 12. Each bar represents the mean +−S.D. of six animals. *P < 0.05 compared with db + / + m + vehicle; §P < 0.01 compared with db + / + m + vehicle; #P < 0.01 compared with db + /db + + vehicle.

Journal: Clinical Science

Article Title: Relaxin improves multiple markers of wound healing and ameliorates the disturbed healing pattern of genetically diabetic mice

doi: 10.1042/cs20130105

Figure Lengend Snippet: Figure 7 VEGFR-2 and VE-cadherin staining (A, B) Representative immunohistochemical VEGFR-2 staining of skin wounds samples from diabetic (db + /db + ) mice treated with vehicle (6 μl of 0.9 % NaCl/mouse per day) or RLX (25 μg/mouse per day, subcutaneously) at day 12. Arrows indicate staining positivity. (C, D) Representative immunohistochemical VE-cadherin staining of skin wounds samples from diabetic (db + /db + ) mice treated with vehicle (6 μl of 0.9 % NaCl/mouse per day) or RLX (25 μg/mouse per day, subcutaneously) at day 12. Arrows indicate staining positivity. (C, F) Quantification of VEGFR-2- and VE-Cadherin-positive cells per field in normoglycaemic (db + / + m) and diabetic (db + /db + ) mice treated with vehicle (6 μl of 0.9 % NaCl/mouse per day) or with RLX (25 μg/mouse per day, subcutaneously) at day 12. Each bar represents the mean +−S.D. of six animals. *P < 0.05 compared with db + / + m + vehicle; §P < 0.01 compared with db + / + m + vehicle; #P < 0.01 compared with db + /db + + vehicle.

Article Snippet: Slides were incubated overnight with primary antibody to detect CD31, CD34, MMP-11, VE-cadherin, VEGFR-1 (all from Abcam) and VEGFR-2 (Cell Signaling) as described previously [20].

Techniques: Staining, Immunohistochemical staining